About

Markus Laubscher is Head of the Pharma Business Unit within Orbia F&EM, driving the innovation, delivery and low-GWP transition within the area of medical propellants for respiratory therapies. Driven by Orbia’s purpose to improve outcomes for patients and the planet, he helps shape the future of propellants and their responsible use across the respiratory pharmaceutical industry. With Orbia’s long-standing legacy in respiratory innovation, Mr Laubscher is at the forefront of the transition to next-generation, low-GWP propellants, set to redefine respiratory treatment and reduce environmental impact across the sector.